OTCMKTS:XPHYF

XPhyto Therapeutics Stock Forecast, Price & News

$2.06
+0.17 (+8.99 %)
(As of 04/21/2021 03:59 PM ET)
Add
Compare
Today's Range
$1.94
Now: $2.06
$2.08
50-Day Range
$1.82
MA: $2.15
$2.38
52-Week Range
$1.31
Now: $2.06
$3.10
Volume46,896 shs
Average Volume75,252 shs
Market Capitalization$132.33 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
XPhyto Therapeutics Corp., through its subsidiaries, operates as a biopharma, diagnostics, and cannabis science company in Canada and Germany. It is involved in the production, cultivation, extraction, isolation, formulation, delivery, and sale of medicinal cannabis. The company also provides contract development and consulting services. XPhyto Therapeutics Corp. has development, technology purchase and license agreement with 3a-Diagnostics GmbH for the development and commercialization of real-time, low-cost and easy-to-use screening tests using 3a's pathogen specific biosensors and XPhyto's oral dissolvable drug delivery platform. XPhyto Therapeutics Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.
XPhyto Therapeutics logo

Industry, Sector and Symbol

Industry Drug Manufacturers—Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:XPHYF
CUSIPN/A
CIKN/A
Phone780 818 6422
Employees20
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$132.33 million
Next Earnings DateN/A
OptionableNot Optionable

Headlines

Emerging Markets Report: A Psychedelic Story
March 9, 2021 |  finance.yahoo.com
See More Headlines

MarketRank

Overall MarketRank

0.00 out of 5 stars

Medical Sector

1908th out of 2,025 stocks

Drug Manufacturers—Specialty & Generic Industry

61st out of 82 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$2.06
+0.17 (+8.99 %)
(As of 04/21/2021 03:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive XPHYF News and Ratings via Email

Sign-up to receive the latest news and ratings for XPHYF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











XPhyto Therapeutics (OTCMKTS:XPHYF) Frequently Asked Questions

What stocks does MarketBeat like better than XPhyto Therapeutics?

Wall Street analysts have given XPhyto Therapeutics a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but XPhyto Therapeutics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting XPhyto Therapeutics?

XPhyto Therapeutics saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 1,800 shares, an increase of 500.0% from the March 15th total of 300 shares. Based on an average daily volume of 108,700 shares, the days-to-cover ratio is presently 0.0 days.
View XPhyto Therapeutics' Short Interest
.

Who are XPhyto Therapeutics' key executives?

XPhyto Therapeutics' management team includes the following people:
  • Mr. Hugh A. D. Rogers B.Sc., LL.B, Pres, CEO & Director (Age 41, Pay $143.75k)
  • Mr. Christopher Ross B.Comm, CPA, CGA, Chief Financial Officer (Age 49, Pay $119.79k)
  • Dr. Thomas Beckert, Managing Director of Vektor Pharma

Who are some of XPhyto Therapeutics' key competitors?

What is XPhyto Therapeutics' stock symbol?

XPhyto Therapeutics trades on the OTCMKTS under the ticker symbol "XPHYF."

How do I buy shares of XPhyto Therapeutics?

Shares of XPHYF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is XPhyto Therapeutics' stock price today?

One share of XPHYF stock can currently be purchased for approximately $2.06.

How much money does XPhyto Therapeutics make?

XPhyto Therapeutics has a market capitalization of $132.33 million.

How many employees does XPhyto Therapeutics have?

XPhyto Therapeutics employs 20 workers across the globe.

What is XPhyto Therapeutics' official website?

The official website for XPhyto Therapeutics is www.xphyto.com.

How can I contact XPhyto Therapeutics?

The company can be reached via phone at 780 818 6422.


This page was last updated on 4/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.